Plasma miR-126 as a potential marker predicting major adverse cardiac events in dual antiplatelet-treated patients after percutaneous coronary intervention
Xi‐Yong Yu(State Key Laboratory of Respiratory Disease), Shilong Zhong(Guangdong Academy of Medical Sciences), Zhiwei Zhang, Hong Wu(Ministry of Education of the People's Republic of China), Yaling Han(Harbin Medical University), Zhihong Chen(Cell Technology (China)), Liwen Li(St. Jude Children's Research Hospital), Jiyan Chen(Guangdong Provincial Center for Disease Control and Prevention), Qiu-Xiong Lin, Zhiwei Zheng(Fujian Medical University)
Cited by 40
Related Papers
Synthetic furanones inhibit quorum-sensing and enhance bacterial clearance in Pseudomonas aeruginosa lung infection in mice
|Journal of Antimicrobial Chemotherapy|2004|444
Protein <i>trans</i> -splicing by a split intein encoded in a split DnaE gene of <i>Synechocystis</i> sp. PCC6803
|Proceedings of the National Academy of Sciences|1998|378
Size-Dependent Cell Uptake of Protein-Coated Graphene Oxide Nanosheets
|ACS Applied Materials & Interfaces|2012|364
Empagliflozin, a sodium glucose co-transporter-2 inhibitor, alleviates atrial remodeling and improves mitochondrial function in high-fat diet/streptozotocin-induced diabetic rats
|Cardiovascular Diabetology|2019|296
Current understanding of multi‐species biofilms
|International Journal of Oral Science|2011|234